Melanoma Clinical Trial
Circulating Tumor Material in Colorectal Cancer and Melanoma
Summary
Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma
Eligibility Criteria
Inclusion Criteria:
The subject must be a patient at the Hospital of the University of Pennsylvania
Patients with presumed stage II, III, or IV colorectal cancer with planned surgical resection of either the primary tumor or metastatic lesion(s) being evaluated at the Hospital of the University of Pennsylvania
Patients with histologically confirmed melanoma stage IIb, IIc, IIIa, IIIb, or IIIc/IV scheduled for surgical resection being evaluated at the Hospital of the University of Pennsylvania.
The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf.
The subject must be 18 years of age or older.
Exclusion Criteria:
The subject is not able to provide informed consent.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19104, United States
How clear is this clinincal trial information?
